Fig 1.
Map of the study area in the Tigray Region, northern Ethiopia, July 2018 to August 2019.
Fig 2.
Flow of the procedure followed for all patients recruited in the study in the Tigray Region, northern Ethiopia, July 2018 to August 2019.
Table 1.
Rifampicin resistance patterns of isolates based on MTB status category of study participants in the Tigray Region, northern Ethiopia, July 2018 to August 2019.
Table 2.
Drug resistance patterns of isolates to first- and second-line anti-TB drugs with TB patient category of study participants in the Tigray Region, northern Ethiopia, July 2018 to August 2019.
Fig 3.
Zonal distribution of 38 MDR-TB among TB patients (N = 227) in the Tigray Region, northern Ethiopia, July 2018 to August 2019.
Table 3.
Sociodemographic and behavior factors associated with MDR-TB among the study participants in the Tigray region, northern Ethiopia, July 2018 to August 2019.
Table 4.
Associations of TB/HIV co-infection and contact history with MDR-TB among study participants in the Tigray region, northern Ethiopia, July 2018 to August 2019.
Table 5.
Associations of clinical presentations with MDR-TB among study participants in the Tigray Region, northern Ethiopia, July 2018 to August 2019.